Fig. 8
From: NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses
(A) Stemness scores based on DNA methylation derived from the Stemness group.(B) Stemness scores based on RNA expression derived from the Stemness group. *P < 0.05.
